#JLABSTMC resident company, Neurogene, announced today that they have secured $68.5M in Series A financing. Excited to see where this takes them as they continue to use #GeneTherapy to fight devastating neurological diseases. https://t.co/ZxBFLjg7vv
Our #JNJ Vice Chairman, @joaquinduato featured in an extensive cover story in @LifeSciLeader1 Magazine discussing Johnson & Johnson’s partnering and innovation-building model, including @jnjinnovation@JLABS - @JNJNews @RfwrightLSL https://t.co/dJcI3A0iwu
See all the great milestones that make #JNJ the healthcare leader that it is today, including @JLABS, by visiting the 133 Years of Innovative Credo-Driven Decisions timeline at https://t.co/LCtm4c53LG https://t.co/OOn7EZdLE7 - #Innovation@JNJInnovation#JLABS#MyCompany
To mark the 75th anniversary of #JNJ going public, take a look at the Credo-driven decisions, acquisitions and inventions beginning in 1886 that have made the company the healthcare leader it is today: https://t.co/DJ4kWYYXtK